Jill Ogden
Corporate Officer/Principal bij Warwick Effect Polymers Ltd.
Actieve functies van Jill Ogden
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Warwick Effect Polymers Ltd.
Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers. | Corporate Officer/Principal | - | - |
Loopbaan van Jill Ogden
Eerdere bekende functies van Jill Ogden
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Andaris Group
Andaris Group Miscellaneous Commercial ServicesCommercial Services Part of Perrigo Co. Plc, Andaris Group is a British company that researches and develops physical, engineering, and life sciences. The company is based in Ruddington, UK. Andaris Group was acquired by Quadrant Healthcare Plc, part of Perrigo Co. Plc from January 11, 2001 on November 05, 1998 for $22.04 million. | Corporate Officer/Principal | - | - |
pSiMedica Ltd.
pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Corporate Officer/Principal | - | - |
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Corporate Officer/Principal | - | - |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Verenigd Koninkrijk | 5 |
Ierland | 2 |
Operationeel
Corporate Officer/Principal | 5 |
Sectoraal
Commercial Services | 3 |
Health Technology | 3 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Warwick Effect Polymers Ltd.
Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers. | Process Industries |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
pSiMedica Ltd.
pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Commercial Services |
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Health Technology |
Andaris Group
Andaris Group Miscellaneous Commercial ServicesCommercial Services Part of Perrigo Co. Plc, Andaris Group is a British company that researches and develops physical, engineering, and life sciences. The company is based in Ruddington, UK. Andaris Group was acquired by Quadrant Healthcare Plc, part of Perrigo Co. Plc from January 11, 2001 on November 05, 1998 for $22.04 million. | Commercial Services |
- Beurs
- Insiders
- Jill Ogden
- Ervaring